Use of a fatty acid composition comprising at least one of EPA and DHA or any combinations thereof
AssigneePronova Biopharma Norge AS
InventorsMorten Bryhn, Jan Kopecky
Life of this patent
Estimating the term…
Loading patent…
AssigneePronova Biopharma Norge AS
InventorsMorten Bryhn, Jan Kopecky
Estimating the term…
A method is disclosed for treatment and prevention of obesity, an overweight condition or for controlling body weight reduction, wherein an effective amount of a fatty acid composition comprising at least one of (all-Z omega-3)-5,8,11,14,17-eicosapentaenoic acid (EPA) and (all-Z omega-3)-4,7,10,13,16,19-docosahexaenoic acid (DHA) or any combinations thereof, is administered to a human or an animal. Additionally, a dietary product is disclosed, containing a fatty acid composition comprising at least one of EPA and DHA or any combinations thereof, for non-medical treatment of obesity, an overweight condition and/or for supporting and controlling body weight reduction. Finally, a method is disclosed for supplementing a dietary product with a fatty acid composition mentioned above.
A method for at least one of treatment of obesity, prevention of obesity, treatment of an overweight condition, prevention of an overweight condition, controlling body weight reduction, and prevention of body weight gain, comprising:
A method for supplementing a dietary product comprising:
A method for at least one of treatment of obesity, prevention of obesity, treatment of an overweight condition, prevention of an overweight condition, controlling body weight reduction, and prevention of body weight gain, comprising:
Dependencies are inferred from the claim text.